论文部分内容阅读
我们应用HBsAg iRNA穴位注射对50例HBsAg阳性的慢活肝、慢迁肝和无征状HBsAg携带者进行了治疗,初步观察结果显效和有效率分别为36.0%和38%。
We applied HBsAg iRNA acupoint injection to treat 50 HBsAg-positive slow-moving liver, slow-moving liver and non-symptom HBsAg carriers. The primary and effective results were 36.0% and 38% respectively.